Apoptotic pathway protein expression variance in metal oxide and quantum dot treated HeLa cells

MicroPubl Biol. 2023 Jul 18:2023:10.17912/micropub.biology.000801. doi: 10.17912/micropub.biology.000801. eCollection 2023.

Abstract

Using the HeLa cell line as a cancerous model, apoptotic protein expression was assessed upon various nanoparticle treatments. Utilizing a known chemotherapeutic agent, cisplatin, as a positive control for induction of apoptosis, several metal oxides (ZnO and CuO) and quantum dots (CdSe/ZnS and InP/ZnS) were investigated for their ability to express apoptotic markers. ZnO, CuO, green CdSe/ZnS, and green InP/ZnS were treated for 24 hours at their IC50 value. Western blot techniques were used to measure protein expression of phosphorylated p53 (ser15), PUMA, and p21 which are involved in signal transduction of apoptosis. CuO, ZnO, and CdSe/ZnS demonstrated considerable p53 activation at 24 hrs compared to the non-treated control. At the IC50 value, CdSe/ZnS quantum dots were the quickest at activating p53 by phosphorylation at the Serine 15 residue. Together, our results provide new insight into the apoptotic mechanism behind these treatments and lead to improved treatments against cancer.

Grants and funding

This work was funded by the U.S. Army Engineer Research and Development Center–Environmental Laboratory (ERDC-EL) through the Environmental Risk Assessment Research Area; Contract No. W912HZ-22-C0014. Any opinions, findings, conclusions, or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of ERDC-EL.